Effects of Nintedanib in an Animal Model of Liver Fibrosis

Systemic sclerosis can affect multiple internal organs, including the liver and lungs. Nintedanib, an antifibrotic approved for treatment of interstitial lung disease associated with systemic sclerosis, may have activity outside of the lungs. This study explored the effect of preventive and therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollin, Lutz, Togbe, Dieudonnée, Ryffel, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150695/
https://www.ncbi.nlm.nih.gov/pubmed/32337244
http://dx.doi.org/10.1155/2020/3867198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150695/
https://www.ncbi.nlm.nih.gov/pubmed/32337244
http://dx.doi.org/10.1155/2020/3867198

Ejemplares similares